Page last updated: 2024-08-24

valsartan and Hypokalemia

valsartan has been researched along with Hypokalemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cox, E; Ishigami, J; Miller, ER; Moran, AE; Pfister, M; Qin, L; Zhang, N1
Alvarado, R; Glazer, R; Graff, A; Huang, J; Pool, JL; Weinberger, M1

Reviews

1 review(s) available for valsartan and Hypokalemia

ArticleYear
Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations.
    Journal of human hypertension, 2022, Volume: 36, Issue:11

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Hypokalemia; Tetrazoles; Valsartan

2022

Trials

1 trial(s) available for valsartan and Hypokalemia

ArticleYear
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Clinical therapeutics, 2007, Volume: 29, Issue:1

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia; Male; Middle Aged; Tetrazoles; Valine; Valsartan

2007